DSM Venturing co-led a $22.5m round for Miach Orthopaedics, which is developing an implant to treat ACL injuries.

PSL Innovation Fund has backed Gleamer, an automated radiology image analysis platform co-founded by a former École normale supérieure research student.

University of Manchester’s UMI3 has joined Frontier IP and Ingenza as a shareholder in newly-founded Plymouth antibiotics spinout Amprologix.

Stanford-StartX Fund-backed microbial diagnostics and wellness product developer UBiome has raised $83m in series C funding.

Microbial diagnostics and wellness product developer uBiome has received series C funding in a Dentsu Ventures-backed round.

Multi-university TTO Satt Sud-Est has licensed patents to GenOmnis for an RNA-based bioinformatics technology that will assess the pathogenicity of biological organisms.

Principia Biopharma, whose drug discovery platform is based on research at UCSF, has completed a $122m initial public offering after underwriters exercised their greenshoe option.

The Novo-backed medical implant provider has filed to raise up to $97.8m in an initial public offering that comes after $103m in funding.

The MIT-affiliated Engine Fund has achieved a final close of more than $205m, above its initial target of $150m.

Institut Curie has supplied an undisclosed sum to its second immuno-oncology spinout, Honing Biosciences, which will focus on improved drug delivery mechanisms.